Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Novocure Ltd.
DescriptionNon-invasive portable device that disrupts the division of cancer cells in the ovaries using low-intensity, alternating electric fields at 200 kHz
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Electromagnetic
Latest Stage of DevelopmentPhase II
Standard IndicationOvarian cancer
Indication DetailsTreat recurrent ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today